Developmental anomaly of metabolic origin
MONDO:0015327383 clinical trials for this condition and its sub-types, 0 tagged with Developmental anomaly of metabolic origin itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Developmental anomaly of metabolic origin
-
Inborn mitochondrial metabolism disorder 59 trials · 127 incl. sub-types
14 sub-types
- Mitochondrial oxidative phosphorylation disorder 3 trials · 58 incl. sub-types Sub-types →
- Inborn mitochondrial myopathy 18 trials · 45 incl. sub-types Sub-types →
- Pyruvate dehydrogenase deficiency 2 trials · 4 incl. sub-types Sub-types →
- Histiocytoid cardiomyopathy 3 trials Sub-types →
- Fumaric aciduria 2 trials
- OPA1-related optic atrophy with or without extraocular features 1 trial Sub-types →
- Inherited lipoic acid biosynthesis defect 0 trials · 1 incl. sub-types Sub-types →
- Multiple acyl-CoA dehydrogenase deficiency 1 trial Sub-types →
- 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome 0 trials
- HSD10 mitochondrial disease 0 trials Sub-types →
- Hypotonia-cystinuria syndrome 0 trials Sub-types →
- Mitochondrial membrane transport disorder 0 trials Sub-types →
- Mitochondrial pyruvate carrier deficiency 0 trials
- Oxoglutaricaciduria 0 trials
-
Fabry disease 64 trials
-
Mucopolysaccharidosis 14 trials · 61 incl. sub-types
8 sub-types
- Mucopolysaccharidosis type 2 24 trials Sub-types →
- Mucopolysaccharidosis type 3 7 trials · 18 incl. sub-types Sub-types →
- Mucopolysaccharidosis type 1 11 trials · 16 incl. sub-types Sub-types →
- Mucopolysaccharidosis type 4 2 trials · 10 incl. sub-types Sub-types →
- Mucopolysaccharidosis type 6 8 trials Sub-types →
- Mucopolysaccharidosis type 7 8 trials
- Mucopolysaccharidosis type 9 1 trial
- Mucopolysaccharidosis, type 10 0 trials
-
Sterol biosynthesis disorder 0 trials · 45 incl. sub-types
7 sub-types
- CHILD syndrome 37 trials
- Cholesterol biosynthetic process disease 2 trials · 6 incl. sub-types Sub-types →
- Mevalonate kinase deficiency 3 trials · 4 incl. sub-types Sub-types →
- Greenberg dysplasia 2 trials
- X-linked chondrodysplasia punctata 1 trial Sub-types →
- MEND syndrome 0 trials
- Microcephaly-congenital cataract-psoriasiform dermatitis syndrome 0 trials
-
Fanconi anemia 29 trials · 42 incl. sub-types
22 sub-types
- Fanconi anemia complementation group D1 6 trials
- Fanconi anemia complementation group A 4 trials
- Fanconi anemia complementation group E 4 trials
- Fanconi anemia complementation group N 2 trials
- Fanconi anemia, complementation group S 2 trials
- Fanconi anemia complementation group B 0 trials
- Fanconi anemia complementation group C 0 trials
- Fanconi anemia complementation group D2 0 trials
- Fanconi anemia complementation group F 0 trials
- Fanconi anemia complementation group G 0 trials
- Fanconi anemia complementation group I 0 trials
- Fanconi anemia complementation group J 0 trials
- Fanconi anemia complementation group L 0 trials
- Fanconi anemia complementation group O 0 trials
- Fanconi anemia complementation group P 0 trials
- Fanconi anemia complementation group Q 0 trials
- Fanconi anemia complementation group R 0 trials
- Fanconi anemia complementation group T 0 trials
- Fanconi anemia complementation group U 0 trials
- Fanconi anemia complementation group V 0 trials
- Fanconi anemia, complementation group W 0 trials
- Fanconi anemia, complementation group 10 0 trials
-
Hypophosphatasia 13 trials
8 sub-types
- ALPL-related autosomal dominant hypophosphatasia 0 trials Sub-types →
- ALPL-related autosomal recessive hypophosphatasia 0 trials Sub-types →
- Adult hypophosphatasia 0 trials
- Childhood hypophosphatasia 0 trials
- Infantile hypophosphatasia 0 trials
- Moderate hypophosphatasia 0 trials
- Odontohypophosphatasia 0 trials
- Prenatal benign hypophosphatasia 0 trials
-
Oligosaccharidosis 0 trials · 11 incl. sub-types
7 sub-types
- Alpha-mannosidosis 5 trials Sub-types →
- Aspartylglucosaminuria 4 trials
- Fucosidosis 2 trials
- Galactosialidosis 2 trials
- Sialidosis 1 trial · 2 incl. sub-types Sub-types →
- Alpha-N-acetylgalactosaminidase deficiency 0 trials Sub-types →
- Beta-mannosidosis 0 trials
-
Pseudohypoparathyroidism 8 trials · 9 incl. sub-types
5 sub-types
- Pseudohypoparathyroidism type 1A 7 trials
- Pseudopseudohypoparathyroidism 2 trials
- Pseudohypoparathyroidism type 1B 0 trials
- Pseudohypoparathyroidism type 1C 0 trials
- Pseudohypoparathyroidism type 2 0 trials
-
Zellweger spectrum disorders 6 trials · 7 incl. sub-types
15 sub-types
- Peroxisome biogenesis disorder due to PEX1 defect 0 trials · 1 incl. sub-types Sub-types →
- Peroxisome biogenesis disorder 9B 0 trials
- Peroxisome biogenesis disorder due to PEX10 defect 0 trials Sub-types →
- Peroxisome biogenesis disorder due to PEX11B defect 0 trials Sub-types →
- Peroxisome biogenesis disorder due to PEX12 defect 0 trials Sub-types →
- Peroxisome biogenesis disorder due to PEX13 defect 0 trials Sub-types →
- Peroxisome biogenesis disorder due to PEX14 defect 0 trials Sub-types →
- Peroxisome biogenesis disorder due to PEX16 defect 0 trials Sub-types →
- Peroxisome biogenesis disorder due to PEX19 defect 0 trials Sub-types →
- Peroxisome biogenesis disorder due to PEX2 defect 0 trials Sub-types →
- Peroxisome biogenesis disorder due to PEX26 defect 0 trials Sub-types →
- Peroxisome biogenesis disorder due to PEX3 defect 0 trials Sub-types →
- Peroxisome biogenesis disorder due to PEX5 defect 0 trials Sub-types →
- Peroxisome biogenesis disorder due to PEX6 defect 0 trials Sub-types →
- Peroxisome biogenesis disorder, complementation group 2 0 trials
-
Cockayne syndrome 6 trials
4 sub-types
- Cockayne spectrum with or without cerebrooculofacioskeletal syndrome 0 trials
- Cockayne syndrome type 1 0 trials
- Cockayne syndrome type 2 0 trials
- Cockayne syndrome type 3 0 trials
-
Creatine transporter deficiency 6 trials
-
Mucolipidosis 4 trials · 5 incl. sub-types
2 sub-types
- Familial mucolipidosis 0 trials · 5 incl. sub-types Sub-types →
- GNPTAB-mucolipidosis 0 trials Sub-types →
-
Classic homocystinuria 4 trials
-
Mucosulfatidosis 4 trials
-
AICA-ribosiduria 1 trial
-
Nijmegen breakage syndrome 1 trial
-
2 sub-types
-
Occipital horn syndrome 1 trial
-
Encephalopathy due to sulfite oxidase deficiency 0 trials · 1 incl. sub-types
2 sub-types
- Sulfite oxidase deficiency due to molybdenum cofactor deficiency 0 trials · 1 incl. sub-types Sub-types →
- Isolated sulfite oxidase deficiency 0 trials
-
ALDH18A1-related de Barsy syndrome 0 trials
-
Al-Gazali syndrome 0 trials
-
CADDS 0 trials
-
CHIME syndrome 0 trials
-
2 sub-types
-
3 sub-types
-
Larsen-like syndrome, B3GAT3 type 0 trials
-
Neu-Laxova syndrome 0 trials
3 sub-types
- Neu-Laxova syndrome 1 0 trials
- Neu-Laxova syndrome 2 0 trials
- Neu-laxova syndrome due to 3-phosphoserine phosphatase deficiency 0 trials
-
Peters plus syndrome 0 trials
-
SHORT syndrome 0 trials
-
SLC39A8-CDG 0 trials
-
Wiedemann-Rautenstrauch syndrome 0 trials
-
4 sub-types
-
Cutis laxa, autosomal dominant 3 0 trials
-
6 sub-types
- Hyperphosphatasia with intellectual disability syndrome 1 0 trials
- Hyperphosphatasia with intellectual disability syndrome 2 0 trials
- Hyperphosphatasia with intellectual disability syndrome 3 0 trials
- Hyperphosphatasia with intellectual disability syndrome 4 0 trials
- Hyperphosphatasia with intellectual disability syndrome 5 0 trials
- Hyperphosphatasia with intellectual disability syndrome 6 0 trials
-
Mandibuloacral dysplasia 0 trials
2 sub-types
-
Mucopolysaccharidosis-plus syndrome 0 trials
-
Pontocerebellar hypoplasia type 1 0 trials
3 sub-types
- Pontocerebellar hypoplasia type 1A 0 trials
- Pontocerebellar hypoplasia type 1B 0 trials
- Pontocerebellar hypoplasia, type 1C 0 trials
-
Transketolase deficiency 0 trials
Most studied deeper sub-types
-
One-Time gene therapy aims to halt sanfilippo syndrome
Cure Not yet recruitingResearchers test a one-time gene therapy infusion in children and adults with Sanfilippo syndrome (MPS IIIB), a rare inherited disease that damages the brain and body. The therapy delivers a working copy of the NAGLU gene to help the body make an enzyme that is missing or faulty.…
Phase 1/2 • Sponsor: NeuroGT • Aim: Cure
Last updated Sep 16, 2026 00:00 UTC
-
New hope for kids with sanfilippo syndrome b?
Disease control Not yet recruitingThis early-stage trial tests a new drug called JR-446 in 12 children under 6 with MPS IIIB, a rare genetic disorder that damages the brain and body. The main goal is to see if the drug is safe and tolerable. Researchers will also measure changes in certain substances in the body …
Phase 1/2 • Sponsor: JCR Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can a new pill stop fatty buildup in fabry disease?
Disease control Not yet recruitingThis trial tests whether the drug lucerastat can reduce the buildup of a fatty substance called Gb3 in the kidneys of adult men with Fabry disease who have not received prior treatment. Participants will take lucerastat daily for 18 months and undergo kidney biopsies to measure c…
Phase 3 • Sponsor: Idorsia Pharmaceuticals Ltd. • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Can a Two-Drug immune attack shrink Hard-to-Treat pancreatic tumors?
Disease control Not yet recruitingThis phase 2 trial is testing whether combining two immunotherapy drugs—vilastobart and retifanlimab—can shrink tumors in people with metastatic pancreatic cancer that has a BRCA1, BRCA2, or PALB2 gene mutation. Participants receive both drugs by IV infusion over several months. …
Phase 2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Can a common supplement shrink fatty liver in a rare diabetes?
Disease control Not yet recruitingThis trial tests whether taking coenzyme Q10 (CoQ10) for 12 weeks can reduce fat buildup in the liver of people with mitochondrial diabetes, a rare form of diabetes caused by mitochondrial dysfunction. Participants with the m.3243A>G mutation will take 300 mg of CoQ10 daily, and …
Sponsor: The 95th Hospital of Putian,Putian, Fujian, China • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Hope for sanfilippo kids: Brain-Infused drug enters final testing
Disease control Not yet recruitingThis phase 3 trial tests a drug called tralesinidase alfa in 14 children aged 1-5 with Sanfilippo syndrome type B, a rare genetic disease that causes severe brain damage. The drug is given directly into the brain fluid to replace a missing enzyme. The goal is to see if it can slo…
Phase 3 • Sponsor: Spruce Biosciences • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Can a new oral drug help tame leigh syndrome?
Disease control Not yet recruitingThis trial tests an experimental oral drug, TTI-0102, in people aged 5 to 55 with Leigh syndrome spectrum, a rare genetic disorder that damages the brain and nerves. The study aims to find the right dose and check safety over 12 weeks of twice-daily treatment. Participants will h…
Phase 2 • Sponsor: Thiogenesis Therapeutics, Inc. • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Sugar supplement may calm seizures and stomach troubles in rare genetic disease
Disease control Not yet recruitingThis study tests whether a sugar called D-galactose (AVTX-801) can help people with SLC35A2-CDG, a rare inherited disorder that disrupts how the body adds sugar to proteins. The trial enrolls about 10 people of any age who have seizures or chronic digestive issues. Participants r…
Phase 2 • Sponsor: Eva Morava-Kozicz • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Could a stem cell shot before birth fix fanconi anemia?
Disease control Not yet recruitingThis early-phase trial tests whether giving healthy stem cells from the mother to a fetus diagnosed with Fanconi anemia can safely improve the baby's blood cell production. The treatment is a one-time injection into the fetus during pregnancy. The study will enroll 12 pregnant wo…
Phase 1/2 • Sponsor: Agnieszka Czechowicz • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Experimental drug aims to boost energy in rare genetic disorders
Disease control Not yet recruitingThis study tests an oral drug called glycerol tributyrate in 24 adults with MELAS or LHON-Plus, two rare mitochondrial diseases that cause severe symptoms like strokes and vision loss. The trial is open-label (everyone gets the drug) and uses each person as their own control over…
Phase 1/2 • Sponsor: George Washington University • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New Bone-Strengthening device for osteoporosis under review
Disease control Not yet recruitingThis study will review medical records and call patients who received AGN1 LOEP, a device injected into the hip bone to treat osteoporosis. Researchers want to see how many patients later had hip fractures and whether any side effects occurred. The goal is to understand how well …
Sponsor: AgNovos Healthcare, LLC • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Lifestyle makeover tested as MS symptom fighter
Disease control Not yet recruitingThis study tests whether a structured 12-week program focusing on nutrition, exercise, sleep, and stress management can improve fatigue, physical function, and quality of life in people with relapsing-remitting multiple sclerosis. Thirty participants will first be observed for 12…
Sponsor: New York University Abu Dhabi • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Gene therapy hope for rare childhood disease AGU
Disease control Not yet recruitingThis early-stage trial tests a single dose of a gene therapy called DANAGALEX in 9 adults and children with aspartylglucosaminuria (AGU), a rare genetic disorder. The goal is to see if the treatment is safe and can reduce harmful substances in the body. Researchers will monitor s…
Phase 1/2 • Sponsor: Rare Trait Hope • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Could your own stem cells fight this rare brain disorder?
Disease control Not yet recruitingThis study tests whether a person's own stem cells, processed and given by IV, can safely help with multiple system atrophy (MSA) — a rare, worsening brain disease that affects movement and automatic body functions like blood pressure. Fifty adults aged 35 to 65 will receive eith…
Phase 2 • Sponsor: Biocells Medical • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New hope for rare genetic disorder: tailored chemo before stem cell transplant
Disease control Not yet recruitingThis study tests whether a lower dose of the chemotherapy drug treosulfan, given before a stem cell transplant, can help people with Nijmegen breakage syndrome. The condition causes immune problems and a high risk of cancer. The trial will enroll 24 patients, giving a lower dose …
Phase 2 • Sponsor: Federal Research Institute of Pediatric Hematology, Oncology and Immunology • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Could vitamin B3 save sight in rare genetic blindness?
Disease control Not yet recruitingThis early study tests whether high-dose vitamin B3 (nicotinamide) can help preserve or improve vision in people with Leber's hereditary optic neuropathy (LHON), a rare genetic disease that causes sudden vision loss. Researchers will give 13 participants 2 grams of vitamin B3 dai…
Phase 1 • Sponsor: University Hospital, Angers • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New DNA test could end years of uncertainty for mitochondrial disease patients
Diagnosis Not yet recruitingThis pilot study aims to develop a new digital PCR technique to more accurately diagnose mitochondrial diseases. Researchers will test the method on blood, urine, saliva, and muscle fiber samples from 4 patients. If validated, the technique could be faster and cheaper than curren…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Diagnosis
Last updated Jun 27, 2026 12:04 UTC
-
A simple brush could spot mouth cancer early in fanconi anaemia patients
Diagnosis Not yet recruitingPeople with Fanconi anaemia have a high risk of developing oral cancer, but standard biopsies are painful and risky due to their genetic sensitivity. This study tests a non-invasive oral brushing technique to detect early cancer cells in 115 patients aged 15 and older. If accurat…
Sponsor: Institut Jean-Godinot • Aim: Diagnosis
Last updated Jun 27, 2026 07:58 UTC
-
Could a daily supplement recharge aging cells?
Prevention Not yet recruitingThis trial tests whether taking coenzyme Q10 (CoQ10) for 10 weeks can improve biological resilience in adults aged 65 and older who show early signs of frailty. Participants will be randomly assigned to receive either 200 mg of CoQ10 daily or a placebo. The study will measure cha…
Sponsor: University Medical Centre Ljubljana • Aim: Prevention
Last updated Aug 21, 2026 00:00 UTC
-
New study tests which laser technique clears kidney stones faster
Symptom relief Not yet recruitingThis study compares two ways to break up kidney stones using a laser and a suction device. One method turns stones into dust, the other into small fragments. The goal is to see which leaves fewer stone pieces behind after one month. About 86 adults with small kidney stones will t…
Sponsor: Bir Hospital • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Could you help scientists unlock genetic cancer secrets?
Knowledge-focused Not yet recruitingThis study screens up to 1,000 people with personal or family histories of certain cancers to see if they qualify for ongoing genetics research at the National Cancer Institute. Participants fill out a 15-20 minute online survey about their health and family history. No treatment…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Smartphone videos could unlock secrets of rare brain disease
Knowledge-focused Not yet recruitingThis study tracks how Sanfilippo syndrome type C, a rare genetic disorder that affects the brain, progresses over time. Caregivers of children and young adults aged 1 to 25 will record videos of daily activities and answer questionnaires using a smartphone app every six months fo…
Sponsor: Phoenix Nest • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
Dental scans and AI could spot rare bone diseases faster
Knowledge-focused Not yet recruitingThis study will take 3D scans of the inside of the mouth from 240 people with rare bone or cartilage diseases and from healthy volunteers. Researchers will use shape analysis and artificial intelligence to see if these scans can help tell different diseases apart. The goal is to …
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Scientists probe cellular 'Power Plants' to unlock secrets of aging
Knowledge-focused Not yet recruitingThis study looks at how aging changes tiny parts of our cells called mitochondria, which produce energy. Researchers will take small skin samples and blood from 90 healthy adults aged 18-90 to measure inflammation and cell aging markers. The goal is to better understand why we ag…
Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
New study aims to unravel Parkinson's protein mysteries
Knowledge-focused Not yet recruitingThis study looks at how abnormal proteins, like alpha-synuclein and tau, build up and affect brain function in people with Parkinson's disease. Researchers will use brain scans, blood tests, and skin biopsies to track these changes. The goal is to find better ways to diagnose and…
Sponsor: University of Pavia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Fabry disease diagnosis differs between men and women, new study aims to find out how
Knowledge-focused Not yet recruitingThis study will survey 200 adults with Fabry disease to understand how men and women experience different paths to diagnosis. Researchers want to see if symptoms or family screening lead to diagnosis more often in one sex, and how long diagnosis takes. The goal is to identify pat…
Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Could a PET scan spot heart trouble in fabry disease before It's too late?
Knowledge-focused Not yet recruitingThis study will test a special PET scan tracer and blood tests to better understand and predict heart damage in people with Fabry disease. Researchers will look at heart tissue samples and blood markers from 20 adult patients. The goal is to find new ways to diagnose and forecast…
Sponsor: Núcleo de Apoio à Investigação Clínica - FMUP • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
New study aims to unmask hidden causes of childhood joint stiffness
Knowledge-focused Not yet recruitingThis study will look at 35 children with joint problems that are not caused by inflammation, such as stiffness or deformity. Researchers will use exams, lab tests, and imaging to find the true cause, which could be rare genetic conditions like mucopolysaccharidoses or osteogenesi…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:17 UTC